As pharma companies begin reporting earnings next week, investors could be forgiven for paying more attention…
Tag: Bristol Myers Squibbo
Long Covid is an elusive target for Big Pharma
This is the second column in the three-part Heard on the Street series on Long Covid.…
Big Pharma will not grant bail to battered biotech
Share Market It may have been in a recession, but the Biotechnology Index has fallen off…
Bristol-Myers to buy Turning Point Therapeutics for $4.1 billion
Bristol-Myers Squibb Company said it has agreed to buy clinical-stage precision-oncology company Turning Point Therapeutics Deepening…